Allergy Therapeutics PLC Sustainability Reports

Allergy Therapeutics plc is an international commercial biotechnology company focused on the treatment and diagnosis of allergic disorders. The company specializes in the research, development, and sale of aluminum-free subcutaneous and sublingual allergy immunotherapy vaccines.

Sector: Manufacturing

Country: United Kingdom

Exchange: London Stock Exchange (AIM)

LEI: 213800PQ7AHK7KGVOE23

FIGI: BBG001SGQRM9

18 reports from 2006 to 2024

• Allergy Therapeutics PLC 2024 Annual Report and Accounts
• Allergy Therapeutics PLC 2023 Annual Report and Accounts
• Allergy Therapeutics PLC 2022 Annual Report and Accounts
• Allergy Therapeutics PLC 2021 Annual Report and Accounts
• Allergy Therapeutics PLC 2020 Annual Report and Accounts